AA
RGNX icon

Argent Advisors’s Regenxbio RGNX Stock Holding History

Argent Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9
Closed – – 418
2019
Q4 		$0 Buy
+9
New +$356 ﹤0.01% 539

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Argent Advisors's RGNX Position: Q1 2020 in Review

Argent Advisors sold out of Regenxbio (RGNX) in Q1 2020, closing a stake of 9 shares.

Argent Advisors first reported a position in RGNX in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 170 funds tracked by Wall St. Rank hold RGNX as of Q1 2020.

  • Argent Advisors reported no remaining Regenxbio position as of Q1 2020 after selling out during the quarter.
  • Argent Advisors sold 9 Regenxbio shares in Q1 2020.
  • Argent Advisors first reported a position in Regenxbio in Q4 2019 and held it in 1 quarter.
  • Argent Advisors's Regenxbio position peaked at $0 in Q4 2019.
  • 170 funds tracked by Wall St. Rank held Regenxbio as of Q1 2020.

Based on Argent Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.